cohort
Showing 9976 - 10000 of >10,000
Gastrodin on Myocardial Injury in Patients Undergoing Cardiac
Recruiting
- Cardiac Surgical Procedures
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 25, 2023
Gastrodin on Myocardium in Patients Undergoing Cardiac Surgery
Completed
- Cardiac Surgical Procedures
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 25, 2023
Liver Transplant Recipients Colonized With Carbapenem Resistant
Not yet recruiting
- Liver Transplantation
- Carbapenem-Resistant Enterobacteriaceae Colonization
- Application of a prognostic score
-
São Paulo, Brazil
- +5 more
Oct 21, 2022
Anabolic Steroid Overdose, Infertility, Cardiovascular Complication Trial in Copenhagen (No intervention)
Recruiting
- Anabolic Steroid Overdose
- +5 more
- No intervention
-
Copenhagen, DenmarkRigshospitalet
Nov 2, 2022
Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (KRT-232, acalabrutinib)
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
-
Goshen, Indiana
- +44 more
Aug 3, 2022
SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)
Active, not recruiting
- SARS-CoV-2
- mRNA-1273.211
- +6 more
-
Sacramento, California
- +22 more
Nov 16, 2022
An Observational Study on Sarilumab-exposed Pregnancies
Recruiting
- Rheumatoid Arthritis -Exposure During Pregnancy
- Sarilumab SAR153191 (REGN88)
-
New York, New York
- +1 more
Jul 5, 2022
Non-hodgkin Lymphoma, Acute Lymphocytic Leukemia Trial in Saint Louis (Duvelisib)
Recruiting
- Non-hodgkin Lymphoma
- Acute Lymphocytic Leukemia
-
Saint Louis, MissouriWashington University School of Medicine
Jun 30, 2022
Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)
Not yet recruiting
- Leukemia
- Pirtobrutinib
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 7, 2022
Ataxia Trial in Worldwide (Clinical rating scale to measure ataxia disease severity and progression)
Recruiting
- Ataxia
- Clinical rating scale to measure ataxia disease severity and progression
-
Melbourne, Victoria, Australia
- +9 more
Jul 12, 2022
Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in
Not yet recruiting
- Pancreas Adenocarcinoma
- +2 more
- Nab paclitaxel
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023
Spinal Muscular Atrophy 1 Trial in Columbus (AVXS-101)
Completed
- Spinal Muscular Atrophy 1
- AVXS-101
-
Columbus, OhioNationwide Children's Hospital
Aug 30, 2022
Cholera, Cholera Vaccine Toxicity Trial in Boston (PanChol)
Recruiting
- Cholera
- Cholera Vaccine Toxicity
- PanChol
-
Boston, MassachusettsBrigham and Women's Hospital Vaccine Unit
Dec 11, 2022
Immune Response, Safety Trial in Incheon (bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine, quadrivalent influenza
Active, not recruiting
- Immune Response
- Safety
- bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine
- quadrivalent influenza vaccine
-
Incheon, Seo-gu, Korea, Republic ofInternational St. Mary's hospital
Jul 28, 2023
NSCLC Trial in San Antonio (bexmarilimab (FP-1305), Pembrolizumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- bexmarilimab (FP-1305)
- Pembrolizumab
-
San Antonio, TexasMays Cancer Center, UT Health San Antonio
May 13, 2022
Tumor Trial in Quebec (SAR444200, Cemiplimab)
Recruiting
- Neoplasm
- SAR444200
- Cemiplimab
-
Providence, Rhode Island
- +3 more
Oct 17, 2022
Vaccination; Infection, Vaccine Adverse Reaction Trial (Recombinant zoster vaccination)
Not yet recruiting
- Vaccination; Infection
- Vaccine Adverse Reaction
- Recombinant zoster vaccination
- (no location specified)
Jun 9, 2023
Defined (CARD) for Obstetrical Crises: A Multisite Cohort Study
Completed
- Obstetrical Emergency Situations
- CARD
-
Ottawa, Ontario, CanadaThe Ottawa Hospital
Sep 6, 2018
Respiratory Tract Infections Trial in Houston (MeMed BV® biomarker test, Usual care)
Not yet recruiting
- Respiratory Tract Infections
- MeMed BV® biomarker test
- Usual care
-
Houston, TexasThe University of Texas Health Science Center at Houston
Oct 2, 2023
Secondary Attack Rate Measles Vaccine In Second Situation
Completed
- Measles
-
Rio de Janeiro, BrazilEliane Matos dos Santos
Oct 20, 2022
Gastric Cancer, Esophageal Cancer, Stomach Cancer Trial in Saint Louis (CA-4948, 5-FU, Leucovorin)
Not yet recruiting
- Gastric Cancer
- +4 more
- CA-4948
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 27, 2022
Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)
Recruiting
- Osteoporosis, Postmenopausal
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Jackson, MississippiUniversity of Mississippi Medical Center
Aug 5, 2022
Collection of Sputum and Labeling for Lung Cancer
Recruiting
- Lung Cancer
-
Waterbury, Connecticut
- +6 more
Jul 19, 2022